{"uri": "eng-9414551", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Multiple_myeloma", "type": "wiki", "score": 100, "label": {"eng": "Multiple myeloma"}}, {"uri": "http://en.wikipedia.org/wiki/Relapse", "type": "wiki", "score": 100, "label": {"eng": "Relapse"}}, {"uri": "http://en.wikipedia.org/wiki/Disease", "type": "wiki", "score": 100, "label": {"eng": "Disease"}}, {"uri": "http://en.wikipedia.org/wiki/European_Union", "type": "loc", "score": 100, "label": {"eng": "European Union"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Bristol_Myers_Squibb", "type": "wiki", "score": 96, "label": {"eng": "Bristol Myers Squibb"}}, {"uri": "http://en.wikipedia.org/wiki/Immunotherapy", "type": "wiki", "score": 96, "label": {"eng": "Immunotherapy"}}, {"uri": "http://en.wikipedia.org/wiki/European_Commission", "type": "org", "score": 80, "label": {"eng": "European Commission"}}, {"uri": "http://en.wikipedia.org/wiki/CAR_T_cell", "type": "wiki", "score": 75, "label": {"eng": "CAR T cell"}}, {"uri": "http://en.wikipedia.org/wiki/Cell_therapy", "type": "wiki", "score": 60, "label": {"eng": "Cell therapy"}}, {"uri": "http://en.wikipedia.org/wiki/Monoclonal_antibody", "type": "wiki", "score": 57, "label": {"eng": "Monoclonal antibody"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 57, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Progression-free_survival", "type": "wiki", "score": 56, "label": {"eng": "Progression-free survival"}}, {"uri": "http://en.wikipedia.org/wiki/Proteasome_inhibitor", "type": "wiki", "score": 53, "label": {"eng": "Proteasome inhibitor"}}, {"uri": "http://en.wikipedia.org/wiki/Idecabtagene_vicleucel", "type": "wiki", "score": 51, "label": {"eng": "Idecabtagene vicleucel"}}, {"uri": "http://en.wikipedia.org/wiki/Neurotoxicity", "type": "wiki", "score": 51, "label": {"eng": "Neurotoxicity"}}, {"uri": "http://en.wikipedia.org/wiki/Clinical_endpoint", "type": "wiki", "score": 50, "label": {"eng": "Clinical endpoint"}}, {"uri": "http://en.wikipedia.org/wiki/Doctor_of_Medicine", "type": "wiki", "score": 50, "label": {"eng": "Doctor of Medicine"}}, {"uri": "http://en.wikipedia.org/wiki/Cytokine_release_syndrome", "type": "wiki", "score": 43, "label": {"eng": "Cytokine release syndrome"}}, {"uri": "http://en.wikipedia.org/wiki/T_cell", "type": "wiki", "score": 42, "label": {"eng": "T cell"}}, {"uri": "http://en.wikipedia.org/wiki/Japan", "type": "loc", "score": 42, "label": {"eng": "Japan"}, "location": {"type": "country", "label": {"eng": "Japan"}}}, {"uri": "http://en.wikipedia.org/wiki/Switzerland", "type": "loc", "score": 39, "label": {"eng": "Switzerland"}, "location": {"type": "country", "label": {"eng": "Switzerland"}}}, {"uri": "http://en.wikipedia.org/wiki/Israel", "type": "loc", "score": 36, "label": {"eng": "Israel"}, "location": {"type": "country", "label": {"eng": "Israel"}}}, {"uri": "http://en.wikipedia.org/wiki/Doctor_of_Philosophy", "type": "wiki", "score": 31, "label": {"eng": "Doctor of Philosophy"}}, {"uri": "http://en.wikipedia.org/wiki/Survival_rate", "type": "wiki", "score": 29, "label": {"eng": "Survival rate"}}, {"uri": "http://en.wikipedia.org/wiki/Hematology", "type": "wiki", "score": 27, "label": {"eng": "Hematology"}}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 19, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}], "eventDate": "2024-03-20", "totalArticleCount": 6, "title": {"eng": "EC approves Abecma for multiple myeloma treatment By Investing.com"}, "summary": {"eng": "PRINCETON, N.J. - Bristol Myers Squibb (NYSE: NYSE:BMY) has received approval from the European Commission (EC) for Abecma\u00ae (idecabtagene vicleucel; ide-cel) as a treatment for adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies. This marks the first approval of a chimeric antigen receptor (CAR) T cell immunotherapy in the European Union (EU) for earlier lines of therapy in this patient group.\n\nToday's announcement underscores the company's"}, "location": null, "categories": [{"uri": "dmoz/Health/Conditions_and_Diseases/Cancer", "label": "dmoz/Health/Conditions and Diseases/Cancer", "wgt": 71}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 78}], "articleCounts": {"eng": 6}, "sentiment": 0.2941176470588236, "wgt": 448588800, "relevance": 1}